Loading...
| A03139 | Pages: NA | Aug 2021 | 3920 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Human Placental Protein Market
Request Now !A placenta is an organ that connects the developing fetus to the uterine wall to allow nutrient uptake, thermo-regulation, waste elimination, and gas exchange through the mothers blood supply. In addition, it aids in fighting against internal infection and produces hormones to support pregnancy. This placenta is further hydrolyzed and is used for a variety of applications as it has lactogenic, luteotropic, and growth-promoting action, and prevents maternal insulin action during pregnancy.
The increased use of placental protein in cosmetic products as well as in medications to treat menopause problems will drive the market growth. However, prolonged use of placental protein may cause skin dryness, thus impeding the market growth. Moreover, the increase in R&D investments in healthcare sector coupled with the introduction of human placental protein in pseudo-medicines will create lucrative opportunities for key market players.
Human placental protein market is segmented based on type, applications and geography. Based on type this market is segmented into hydrolyzed human placental protein and others. Further, based on applications this market is segmented into life science, tumor markers, testing/assay validation, and others. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Comprehensive competitive analysis and profiles of major market players such as Japan Bio Products GmbH, R&D Systems, Inc., Abcam plc, Clontech Laboratories, Inc., Lee Biosolutions, Inc., Kamiya Biomedical Company, Scripps Laboratories, VWR International, Elabscience Biotechnology Co.,Ltd and Hunan World Well-Being Bio-Tech Co., Ltd. are provided in this report.
Key Benefits
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
CHAPTER 4 HUMAN PLACENTAL PROTEIN MARKET, BY TYPE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. HYDROLYZED HUMAN PLACENTAL PROTEIN
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. OTHERS
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
CHAPTER 5 HUMAN PLACENTAL PROTEIN MARKET, BY APPLICATION
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. LIFE SCIENCE
5.2.1. Key market trends
5.3. TUMOR MARKERS
5.3.1. Key market trends
5.4. TESTING/ASSAY VALIDATION
5.4.1. Key market trends
5.5. OTHERS
5.5.1. Key market trends
CHAPTER 6 HUMAN PLACENTAL PROTEIN MARKET, BY REGION
6.1. OVERVIEW
6.2. NORTH AMERICA
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast
6.2.4. North America Human Placental Protein Market by Type
6.2.5. North America Human Placental Protein Market by Application
6.3. EUROPE
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Spain market size and forecast
6.3.3.5. Rest of Europe market size and forecast
6.3.4. Europe Human Placental Protein Market by Type
6.3.5. Europe Human Placental Protein Market by Application
6.4. ASIA-PACIFIC
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.3.1. Japan market size and forecast
6.4.3.2. China market size and forecast
6.4.3.3. Australia market size and forecast
6.4.3.4. India market size and forecast
6.4.3.5. Rest of Asia-Pacific market size and forecast
6.4.4. Asia-Pacific Human Placental Protein Market by Type
6.4.5. Asia-Pacific Human Placental Protein Market by Application
6.5. LAMEA
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.3.1. Brazil market size and forecast
6.5.3.2. Turkey market size and forecast
6.5.3.3. Saudi Arabia market size and forecast
6.5.3.4. South Africa market size and forecast
6.5.3.5. Rest of LAMEA market size and forecast
6.5.4. LAMEA Human Placental Protein Market by Type
6.5.5. LAMEA Human Placental Protein Market by Application
CHAPTER 7 COMPANY PROFILES
7.1. JAPAN BIO PRODUCTS GMBH
7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments
7.2. R&D SYSTEMS, INC.
7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments
7.3. ABCAM PLC
7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments
7.4. CLONTECH LABORATORIES, INC.
7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments
7.5. LEE BIOSOLUTIONS, INC.
7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments
7.6. KAMIYA BIOMEDICAL COMPANY
7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments
7.7. SCRIPPS LABORATORIES
7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments
7.8. VWR INTERNATIONAL
7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments
7.9. ELABSCIENCE BIOTECHNOLOGY CO.,LTD
7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments
7.10. HUNAN WORLD WELL-BEING BIO-TECH CO., LTD.
7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
10%
Discount
10%
Discount
10%
Discount
10%
Discount
Enterprise
License/PDF
10%
Discount
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
